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1. ABSTRACT
Topic of the thesis is the analysis of three key aspects of diagnostic and interventional 
radiology in a Breast Center: 1 - monitoring of the radiation dose delivered by 
mammography; 2 – integrated diagnostic approach conducted together by radiologists and 
surgeons (joint CORD); 3 - interdisciplinary meetings.
Radiation dose monitoring
Mammography is still considered the most effective imaging technique for the early 
detection of breast cancer and for mortality reduction. The parameter for estimating the 
absorbed dose is the average glandular dose. 
The purpose of this section of the thesis is to present the data collected from three 
mammography units in the period from January 1 to May 31 2014.
A dose monitoring software (TQM) was used that was able to automatically detect relevant 
indices from X-ray equipments and to analyze the data in terms of variability of dosimetric 
behaviours.
The  “joint CORD”
In the period from January 16 to April 11, 2014 a weekly session handled by a junior breast 
surgeon  and a senior Radiology resident (joint CORD) was established. 
The aim of this session was to optimize the path within the Breast Centre of the patients 
with urgent referral and nonspecific symptoms. In fact, for these patients it is likely that the 
final diagnosis can be already reached with a clinical breast examination and a breast 
ultrasonography.
Twelve sessions of joint CORD were performed, that included 95 patients (average: 7.9 
patients for each session).
Of the 95 patients who had access to this service, 33 had an examination performed 
elsewhere with detection of suspicious nodules or were controls at 6 months of multiple 
fibroadenomatosis; 20 came for palpable lumps; 16 for unilateral or bilateral breast pain; 5 
for mastitis; 5 for swelling / hyperemia or collection after QUART; 4 for secretion (milky); 
and 12 for various reasons (axillary swelling, screening prior hormonal therapies, skin 
nodule, adenoma of the nipple).
Of the 95 patients, besides ultrasound and clinical breast examination, 24 (25.2%) 
underwent mammography, 6 (6.3%) underwent MRI, and 2 (2, 1%) underwent stereotactic 
biopsy.
US-guided cytological examinations were performed  in 23 subjects (24.2%): in 21 cases 
of nodules and in 2 cases of mammary secretions.
 The results of cytology were: 15 C2 (benign findings) with the conclusion of the diagnostic 
iter; 2 C3 (probably benign findings); 4 C1 (inadequate sampling).
The joint CORD allowed patients to finish their diagnostic workup in a single access, thus 
dramatically reducing the time they spent in the breast imaging center.
Interdisciplinary meetings
Interdisciplinary meetings (with breast radiologists and surgeons) were conducted on a 
weekly basis starting from January 17, 2014.
This section of the thesis analyzes the period from January 17 to March 27, 2014.
The cases discussed were tabulated to analyze the most frequent causes of problems, 
possible solutions and improvements for clinical practice.
Eleven meetings were held, discussing a total of 48 cases (average: 4.36 cases discussed 
per meeting).
Of the 48 cases discussed, 11 (22.9%) did not reach a cyto-histological conclusive 
diagnosis, 9 (18.7%) had an underlying lack of communication between radiologists and 
surgeons, 8 (16.6%) required a further biopsy, 6 (12.5%) had an inappropriate  use of 
MRI , 5 (10.4%) required additional MRI, 3 (6.25%) required a shared decision between 
radiologists and surgeons, 2 (4.1%) had a PET inappropriately performed, 2 (4.1%) were 
considered inappropriate for surgical evaluation, and 1 (2.07%) required a new 
mammography.
2. INTRODUCTION
Mammography is  an imaging  technique  that  uses  ionizing  radiation  to  produce  a 
mammogram,  a 2D projection of the breast. It is the main diagnostic tool to identify breast  
cancers and it is used for two main purposes, screening and clinical use. Breast cancer is 
the most  prevalent  cancer  in the female population of  industrialized countries.  Is  very 
important  an early diagnosis of this disease.
A normal breast is composed of adipose tissue and glandular tissue, whose abundance 
weight  percentage  varies  depending  on  the  subjects  and  age.  These  tissues  are 
characterized by poor  natural  contrast  and mammograms should have high quality,  to 
reveal any micro calcifications with size ≈ 100 mM. The main problem is due to the fact  
that the attenuation of X-rays by a pathological tissue is very similar compared to that of a  
healthy breast tissue (Fig.1) and the differences between them are of the order of 4% to 15 
keV, decreasing to 1% at 25 keV. 
                     
Fig.  1 (Left)  Comparison between the linear attenuation coefficient of the carcinoma tissue and adipose 
tissue fibroghiandolare. It is seen that with increasing energy the three curves are getting closer and closer. 
(Right)  values  of  the  linear  attenuation  coefficients  for  adipose  tissue  and  glandular  tissue  at  20  keV 
measured experimentally by several authors (H: Hammerstein et al., W: Woodard and White, J Johns and  
Yaffe). [3] J Johns and Yaffe) [3].
To get a good contrast resolution on the pictures it is important to work with low kV values, 
typically between 25 kV and 40 kV.
2.1 HOW'S MADE A  MAMMOGRAPHY
Mammography is X-ray equipment dedicated and specialized for the study of the breast 
and is made by the following basic elements (Fig. 2):
- X-ray tube 
- compression plate
- removible grate 
- Digital detector
Fig. 2 Principali elementi di un mammografo, montati su di un braccio rotante a forma di C. 
The X-ray tube is constituted by two electrodes, the cathode and the anode. Between 
them is kept a constant potential difference ( in mammography  typically on the order of  
tens of kV). The cathode consists of a tungsten filament wound in a spiral  from which 
electrons are emitted by thermionic effect. These are accelerated towards the anode due 
to the potential  difference between the two electrodes and the impact of  the beam of 
accelerated  electrons  causes  the  generation  of  X-rays  due  to  the  phenomenon  of 
Bremsstrahlung.  The X-ray tube anode can be fixed with  suitable cooling systems, or 
rotating anode in order to spread the heat load over a larger area.
 The  spectrum  of  radiation  produced  by  an  X-ray  tube  is  constant  (Fig.  3)  and  is 
constituted  by  photons  of  different  energy,  from  a  few  keV  up  to  a  maximum  value 
numerically  equal  to the potential  difference applied to the tube:  Emax = kVp.  At the 
bremsstrahlung spectrum overlaps the characteristic radiation: when an electron inside of  
the anode material  is ionized,  it  is  ejected from his orbital  and the gap is filled by  a 
reorganization of the higher energy levels. This process is associated with the emission of 
a photon of energy equal to the energy difference  between the two levels of transition. It  
takes  the  name  of  characteristic  radiation  because  it  is  typical  of  every  element  and 
depends on the type of material of which is made the anode . The characteristic radiation 
covers about 20-30% of the total radiation emitted by the tube.
Fig. 3 Radiation spectrum of an x-ray 
Before hitting the object to scan the beam is filtered with additional metallic materials in 
order to retain the low energy photons, those less penetrating that may be completely 
absorbed by the object target contributing to the dose that it receives, but does not give 
usefull information  for the image formation.
The compression device of the breast has a rectangular shape and is generally composed 
of plastic material. It is used to immobilize and compress the breast in order to make the 
thickness thinner and uniform. The compression of the breast tissue must be the greatest 
possible to obtain a thickness of the breast  approximately uniform, but at the same time 
tolerated by the patient. There is an optimal value for the force, but it is important to check  
the compression applied, and the accuracy of his measure. All scanners must be equipped 
with engine driven compressor.
The mobile/anti-scatter grid, is composed of lead lamellae alternate to radiolucent spaces 
and has the purpose to absorb the scattered photons. It is designed to let pass only those 
X-ray whose direction is on the line perpendicular to the plane of the detector and absorb  
photons directed obliquely.  The grid  is equipped with a mechanism for  the movement 
designed to prevent the display of the lead slats on the mammogram.
The detection system used in mammography is based on the use of Full  Field Digital 
Mammography (FFDM), and according to the revelation of the machinery can be direct or  
indirect.  The  direct  digital  detection  systems  (eg  Giotto  Image  MD)  using  flat  panel 
detectors coupled with a photoconductive amorphous selenium (a-Se), which transforms 
X-rays  directly  into  an  electric  signal.  The  detection  systems  digital  indirect  (eg  GE 
Senographe DS) instead convert the X-rays in the first light signal and then into electric 
charge.  A layer  of  crystals  of  thallium activated cesium iodide (CsI:  Tl)  with  columnar 
structure  converts  X-rays  into  visible  light  which  is  then  absorbed  by  the  array  of  
photodiodes  with  technology  to  amorphous  silicon  (a-Si)  and  converted  into  electric 
charge.
Fig. 4 Photon detection chain with the indirect conversion method. The  charge of each pixel is read through 
an electronic chain, digitized and sent to the computer. The digital image is produced directly on the monitor  
in the work station and readily 
The feature that differentiates different types of mammography is the anode-filter coupling. 
The anode of a mammography  is usually made in molybdenum (Mo, Z = 42) because the 
characteristic radiation produced from it generates two peaks in the spectrum at 17.6 keV 
and 19.7 keV that is in a range of useful energy for mammograms. The molybdenum 
anode has  limits on breast of high thickness and density for which you prefer to use an 
anode that produces a "harder" beam as the Rhodium (Rh, Z = 45), whose characteristic 
radiation has two peaks to higher energies with respect to molybdenum (fig. 5).
  
Fig. 5 Radiation spectrum for two different anodes made by molybdenum and rodium 
Another material often used for the anode is the tungsten (W, Z = 74).
Beam's filtration is obtained by thin thicknesses of molybdenum, rhodium or aluminum. To 
better adapt to the characteristics of the breast tissue, the current mammography have 
several pairs anode-filter: Mo / Mo, Mo / Rh, Rh / Rh, Rh / Mo, W / Al, W / Rh, Rh / Al 
manually or automatically selectable in function of the thickness of the compressed breast  
and of its constitution (abundance percentage of glandular tissue and adipose).
Suitability of the beam of photons to cross the breast is expressed by the value of the Half  
Value Layer (HVL),  function of the peak voltage. In radiology emivalent  thickness of a 
beam of X-rays is the thickness of absorbing material required to reduce the intensity of X-
rays to half of its initial value and is evaluated by measuring the attenuation of the beam 
produced by thin aluminum filters. With the combination anode / filter Mo / Mo and with 
peak voltage equal to or lower than 30 kVp the SEV must be between 0.26 and 0.32 mm 
of Aluminium.
2.2 Dosimetric Units in mammography
Breast is a highly radiosensitive organ and it is necessary to take into account the risk that 
you  present  a  radiation-induced  cancer  following  exposure  to  X-rays  linked  to 
mammographic  procedure.  In  the  new  European  Directive  EURATOM  59/2013  the 
weighting factor wT for breast used to calculate the effective dose was raised to 0.12 
compared to the value 0.05 of the previous Directive EURATOM 43/1997.
Protocols  for  dosimetry  and  quality  control  in  mammography  imaging  systems  are  of 
paramount importance for the estimation of dose to the breast and to minimize the risk  
associated with radiological procedure.
The dose in mammography depends mainly on the quality of the radiation beam and the 
thickness  and  composition  of  the  breast.  Is  important  that  the  radiation  is  more 
monochromatic  and  with  low energy as  possible  in  order  to  define  and  identify  small 
structures  and  to  obtain  a  good contrast  between  the  tissues,  as  seen  in  Fig.7.  The 
compression of the breast is of fundamental importance as it allows the reduction of the 
thickness  and  therefore  the  exposure  time  and  the  dose  of  radiation  administered. 
According the author Fife, range for the compressed breast is between 2.5 cm and 8.6 cm 
with an average value equal to 5.2 cm. The other element of variability is represented by 
the composition of the breast,  which is formed mainly by adipose tissue in childhood,  
which is formed mainly by glandular tissue during puberty; and which glandular tissue is 
gradually replaced by fat in adulthood. The age is not a sufficient indicator of glandularity 
and there are significant variations within a population and in relation to the size of the 
breast. Geise and Palchevsky in a work of 1996 have estimated the glandularity breast 
cancer in a sample of 417 patients and found average values of 68%, 42%, 26% and 16% 
for a thickness of the compressed breast, respectively, equal to ≤ 3 cm, 3-5 cm, 5-7 cm 
and ≥ 7cm.
The dosimetric index chosen  as a parameter to indicate the dose to the glandular tissues 
of the breast is the average glandular dose (AGD = Average Dose Gladular or MGD = 
Mean Glandular Dose), commonly accepted as representative of the risk originated from 
ionizing  radiation  as  a  result  of  irradiation  breast.  Significant  fractions  of  the  energy 
absorbed from the breast in fact are deposited in the skin, fatty tissue and connective 
tissues, but it is believed that is the glandular tissue the one with the highest risk of radio-
induced malignancies. The average glandular dose is the amount recommended by the 
ICRP (International Commission on Radiological Protection) and is used in many protocols 
as the reference in mammography, as in the European protocol "European protocol on 
dosimetry in mammography" EUR 16263 and in Protocol "European guidelines for quality 
assurance in breast cancer screening and diagnosis". 
In fact it is very difficult or impossible to measure the average glandular dose in a direct  
way  for  each  and  every  single  breast  examination;  the  most  simple  and  direct 
measurement to be made is that of the air kerma (ESAK = Entrance Surface Air Kerma) 
without the contribution of the backscattering, at a point corresponding to the input surface 
of the breast. It is necessaire use conversion factors based on models and simulations that 
relate the input air kerma at the surface with the average glandular dose. The air kerma in 
free air must be measured at the entry point of the breast and for different values of kV 
and couplings anode / filter available in the system. To calculate the AGD is necessary to 
know the parameters of exposure and the thickness of the compressed breast.
Conversion factors that are used today are those obtained from Monte Carlo simulations 
by Dance and its employees with a simple model of the breast and mammography imaging 
system.  According  to  this  theory  the  average  glandular  dose  is  calculated  using  the 
formula: D = ESAK · g · c · s
Where the ESAK is the kerma in free air incident on the upper surface of the breast, and g  
is  the  conversion factor  between kerma and average glandular  dose  in  a  breast  with 
glandularity 50%, c is the correction factor for a glandularity different compared to 50 % es 
is the correction factor for the quality of the beam that takes account of different materials 
of the anode and the filter.
To  calculate  the  correction  factors  by  the  method  of  Monte  Carlo  simulation  the 
compressed breast was simulated with a cylinder to said semicircular section (puppet of 
standard breast) of PMMA (polymethylmethacrylate) often 4.5 cm in diameter and 16 cm 
(Fig. 6 left).
                              
Fig. 6  (Left) Standard phantom for breast, cranio-caudal projection of the phantom and cross-sectional 
section perpendicular to the detector plane. (Right). Irradiation geometry used in the Monte Carlo silumation 
by  Dance at al.  The central region mimics a uniform (50 %-50 %) mixture of fat and glandular tissue, 
whereas the white outer layer represents a 0,5 cm thick adipose tissue surrounding the central region from 
all sides expect the chest wall. In this model the photon pathway is traced starting from tube up to the 
detector and this distance is assumed to be 60 cm. The energy delivered in the central mammary region is 
split between adipose and glandular tissue according to the probabilities of interaction of photons with the 2 
types of tissue.
The g factor (mGy / mGy) converts the air kerma free in average glandular dose and is  
valid for a breast with glandularity 50%; it depends on the thickness of the compressed 
breast that used by the couple anode filter and kV. To simplify, the g factor was tabulated 
as a function of the thickness of the beam emivalente (HVL = Half Value Layer) expressed 
in mm of Al in such a way as to have a single table for different pairs anode / filter and kV 
used. In Figure 7 are shown the values  of g calculated for different thicknesses of the 
compressed breast, from 2 cm to 11 cm, and for beams with HVL in the range 0.30-0.60 
mm Al  [4].  The highest  value relates breasts factor  2  cm factor  irradiated with  higher 
energy beams; the values on the diagonal end of the table are approximately 0.3 and this 
means that  about  a  third  of  the  air  kerma incident  on  the  free  surface  of  the  breast  
contributes to the value of the dose absorbed by the glandular tissue. We also note that for  
the same beam quality, more the breast is compressed, more the g value increases. In Fig 
8 is shown the trend of the conversion factor g as a function of the thickness for beams of 
different  quality  and  it  shows  how  this  decreases  as  the  thickness  of  the  breast  in 
agreement with data reported in the table.
Fig. 7:   Values of conversion factor  g (mGy/mGy) for breast thickness between 2 and 11 cm and HLV  
ranging between  0.30 mm Al and  0.60 
Fig. 8:  The value of g as a function of breast thickness stratified according to different Half Value Layer 
between  0,30 mm and  0,60 mm
The s-correction factor consideres the different anode/filter pairs used. For calculations 
have  been  used  the  following  combinations  of  anode  material  and  filtration: 
molibdeno/30μm molybdenum (Mo / Mo), molibdeno/25μm rhodium (Mo / Rh), rodio/25μm 
rhodium (Rh / Rh), rhodium / 1mm aluminum (Rh / Al), tungsteno/50μm rhodium (W / Rh). 
For each of them have been used five values of tube voltage: 25 kV, 26 kV, 28 kV, 30 kV 
and 32 kV. The results are shown in Fig 8 and for simplicity has been assigned a single s 
factor for each combination anode/filter, regardless HVL and the thickness of the breast.  
The right column shows the maximum value of the error that you do with this simplification. 
Also in the Protocol EUREF OF 2006 [6] estimated the value of the correction factor for the 
coupling s tungsten anode and aluminum filter (W / Al) and found to be equal to 1.05.
Fig. 9:  Different correction factor values s for different anode/ filter coupling used
C-factor corrects for breast glandularity which is not 50%. A composition of the standard 
breast with 50% of adipose tissue and 50% of glandular tissue is not real and it varies 
according to the thickness of the breast and the age of the patient. A study on populations 
of women between 40-49 years and 50-64 years in the UK shows how the glandularity  
varies according to the thickness of the breast in these two groups (Fig.10). In Fig.10 are 
shown the values of the composition of the breast that vary between 99.9% and 0.1% of 
the adipose tissue of glandular tissue up to a maximum of 100% of glandular tissue. The 
same results are shown in the tables of Fig.11.
 
Fig.  10: Estimation of the average composition of the breast for different values  of the thickness of the 
compressed breast for women aged between 40 and 49 years (left) and women aged between 50 and 64 
years[4].  
Fig. 11:  Average composition of the breast with 2 different compressions
In light of these results, in order to calculate the average glandular dose c factors were 
calculated for typical breasts in the two different age groups, 40-49 years and 50-64 years 
as shown in Fig.12. For thicknesses less than or equal to 4 cm, the c-value  is less than or  
equal to 1, and this corresponds to a value of glandularity greater than 50% (Fig. 11). For 
thicknesses greater than 4 cm, the c-factor is greater than 1 and this factor contributes to  
increase the final value of the average glandular dose. As noted for the group of women 
aged between 50 and 64 years and for a thickness of compressed breast equal to 4 cm 
the composition of the breast is equal to 50% of glandular tissue and 50% of adipose 
tissue and the factor c is equal to 1 (ie no correction). In Fig 13 is shown the trend of the c 
factor as a function of the thickness of the compressed breast for five different values of 
glandularity.
  
Fig.12:  Estimates of correction factor c as a function of thickness of compressed breast and of the half-value 
for the groups of women with age range between   40-49   (left ) and  50-64
The impact of the c-factor  on the final calculation of the average glandular dose is shown 
in Fig 14. As can be seen the estimate of the average glandular dose considering the c-
factor c is greater than the estimate without the multiplicative factor c for the udder with a  
thickness greater than 4 cm, and this difference becomes more significant as the thickness 
increases. 
In summary then, it is possible to obtain an automatic procedure that allows the calculation 
of AGD in real time for each exposure for single patient once you have available measures 
air kerma of the source for different kV values and for different anode coupled / filter, and 
the thickness of the compressed breast.
Fig. 13:  Variation of correction factor c as a function of the compressed breast thickness with different values 
of  HVL  and  glandularity of  0,1%, 25%, 50%, 75% e 100%
Fig. 14:  Effects of estimates of mean glandular dose obtained by applying correction factor c. ADG corrected 
values are less than original ADG for thicknesses up to 4 mm, and superior for higher thickness values. up to  
values 30 % higher
2.3 INFORMED CONSENT 
Actually in Radiology Breast Imaging the patient  signs informed consents relating to the 
processing of personal data for inclusion in the examination RIS-PACS system connected 
with the air wide, to rule out pregnancy in the event of diagnostic procedures or 
interventional procedures using ionizing radiations, and before undergoing interventional 
procedures.
However, it would be useful and important to introduce a disclosure / consent (currently 
only verbal) concerning mammography in accordance with the recommendations of the 
European Society of Breast Imaging (EUSOBI) 2011.
Such consensus should clarify, after a brief description of the overall objective of 
undergoing regular mammograms, or to obtain an early diagnosis of breast cancer,the 
best time of the menstrual cycle (7-12 th day ) to perform the test and the cadence with 
which  mammography should be performed. It also seems necessary to explain the 
importance to bring any previous X-ray examinations, as some cancers can be diagnosed 
only on the basis of changes from a previous exam.
A good informed consensus should contain a brief description of mammography, how it is 
performed, and the fleeting feeling of pain associated, proven by some of the women who 
undergo the procedure in relation to breast compression, but it is a necessary element for 
a optimization of the examination in terms of radiation dose mammography and legibility, 
and it is important not cause motion artifacts in the brief moment of capture. It is also 
important to invite the patient to relax and focus on the benefits that the compression 
generates.
Mention should be made of the risks from exposure to ionizing radiation in relation to the 
reduction of mortality obtained by the test, the risk of overdiagnosis (approximately 5-20% 
of cancers diagnosed in asymptomatic patients would have remained idle for a lifetime, but 
It is not possible to distinguish these from those that are not treated then fatal) and the 
fallibility of the test may not detect approximately one third of cancers particularly in 
perimenopausal age and in dense breasts. For this it is necessary to highlight that even in 
case of a negative mammogram is important not to underestimate any breast symptoms 
(especially new-onset nodules, skin or nipple retraction, nipple alterations) even if 
insurgents at a short distance from a negative breast examination.
It is understood that any disclosure / consent signed and delivered at the time of the 
waiting room may not in any way replace the necessary oral communication between 
TSRM / doctor and the patient who would rather collect the feed-back received 
informational message.
It is merely an added value and more detailed aims to disseminate accurate information to 
a population too often uninformed. 
It is not, however, write up a simple information that is clear, accurate, relevant and 
therefore effective.
3 RADIATION DOSE MONITORING (DESCRIPTION OF TQM DATA).
Determination  of  the  average  glandular  dose  is  of  paramount  importance  in  order  to 
calculate an estimate of the risk associated with each exam, related to the risk of radio-
induced carcinogenesis associated with mammographic examination,
It 'also important that the dosimetric data are collected and monitored (as required by the 
new European Directive EURATOM 59/2013) laying down basic safety standards for the 
protection  against  the  dangers  arising  from  exposure  to  ionizing  radiation.  In  that 
legislation requires states that the information relates to the exposure of the patient to be 
part  of  the report  of  the radiological  procedure and the equipment used for diagnostic 
radiology are fitted with a device to inform the radiologist of the relevant parameters for the 
evaluation of  the dose to  the patient;  Such equipment shall  also provide the ability  to 
transfer this information in the registration exam. The Directive also addresses the issue of 
the right to information of the patient and is required for the first time to the member states  
that the patient receives adequate information about the risks and benefits associated with 
the radiation dose delivered radiological examination before the exposure takes place.
In view of these major changes, several companies have recently put on the market for 
computer systems acquisition and automatic analysis of dosimetric data. The monitoring of 
the dose can be a great help during all phases of the radiodiagnostic examination and one  
of their important functions is to display the technical parameters of the acquisition of all  
the  tests  carried  out.  This  can  result  in  an  optimization  tool  because  the  radiologist, 
medical physicist  and technologist  can evaluate how to reduce dose while maintaining 
image  quality  appropriate  to  the  diagnostic  question.  At  the  end  of  the  procedure 
radiological monitoring systems allow you to make an assessment of the performance: 
after a short period of time statistics are available on the dose delivered during a single  
test that can be compared with other procedures with the same Study Description,  or  
about the same area of the body. This information allows the rapid detection of incorrect 
behaviors  and  dosimetric  verification  that  they  meet  the  Diagnostic  Reference  Levels 
(DRLs). The software for the monitoring of the dose is installed on the computer network of 
Radiology, the same one that connects the methods, database RIS / PACS workstations 
and reporting. The data collection is done by exploiting some characteristics of the DICOM 
standard, in particular the header, the RDSR (Radiation Dose Structured Report) and the 
MPPS (Modality Performed Procedure Step).
In this section of the thesis work was used the software Total Quality Monitoring (TQM) 
and  dosimetric  data  were  collected  from  the  three  mammography  present  within  the 
premises of Radiology Breast Imaging PACS through interrogation. The Mammographs of 
the unit features are: a mammography Giotto Image MD whose use is limited to large 
breasts,  mammography  and  two  (GE1  and  GE2).  On  Giotto  mammography  is  used 
exclusively anode of tungsten and rhodium filter. The mammography mammography GE1 
and  GE2  have  three  possible  pairs  anode  /  filter:  molybdenum  /  molybdenum, 
molybdenum /  rhodium or rhodium / rhodium that  are used respectively for increasing 
thickness of the compressed breast.
We analyzed data on bilateral mammography examinations RX made by 01/01/2014 to 
05/31/2014 at the U. O. Breast of the University Hospital of Pisa. In this period of time 
were performed in all examinations in 1960, of which 110 mammography exams on the 
Giotto  Image  MD,  393  tests  on  mammography  exams  1457  GE1  and  GE2  on 
mammography (Table 1).
Table 1: Comparison of different instruments  and different procedures in each of them.  
Bilateral mammography examinations represent 76.18% of  all procedures performed and 
the three machines have workloads very different from each other.(Fig 5) The average 
delivered dose is 9.15 mGy for mammography Giotto ( that analyzed the more voluminous 
breasts and has the fixed coupling anode-filter is fixed with tungsten anode and rhodium 
filter), 3.57mGy for mammography and GE1 4.51 mGy for mammography GE2. 
Fig. 15: Workload distribution in the 3 mammographs of  U. O. Senologia of Azienda Ospedaliero 
Universitaria di Pisa and dose values (min,max, mean, and median)  delivered by each instrument  
The different  number  of  exams  performed on  the  three mammography  and  the  dose 
delivered by them is also shown in Fig 16.
Fig. 16:Display of the number of exam per hour in each day of the week (size of the dot) combined with the  
information on the  delivered average dose 
In each of these is shown on the horizontal axis the time of the day (0-23h) and on the 
ordinate the days of the week. The size of the symbols is indicative of the number of  
examinations carried out: a "dot" indicates that few exams are performed  at that precise 
moment  of the day, mind a large "cue ball" means that the machine worked great. color is 
rather indicative of the average dose delivered between all the tests carried out at that  
precise time period: starting from the purple color that indicates a low AGD, to red for the 
highest. From these graphs we see that all  three mammography work from Monday to 
Saturday, from 7:00 a.m.to about 7 p.m. Between noon and 2p.m., the activity is reduced 
on average compared to other times of day.
TQM allows to  examine the performance dell'AGD (mGy)  in function of  time for  each 
device.
Another interesting type of analysis that provides TQM is the trend over time dell'AGD 
relative  to  every  single  examination  done  in  the  period  of  interest  and  distributed  on 
different intervals AGD marked with different colors (Fig. 17). At the center of each of these 
graphs is a horizontal black line indicates the average value of AGD dispensed from the 
machine  in  question.  The two bands  of  bright  green above and below the  black  line  
represents the region in which concentrates 80% of the examinations carried out and the 
green less intense bands represent regions of AGD of the other exams.
Fig. 17: Temporal trend of AGD per exam in the examined time window. In the y-axis, different dose intervals 
with  different colors. The black horizontal line is the average delivered dose of the machine
This type of chart allows you to instantly locate examinations carried out with high dose 
values, and possibly investigate the reason.  Is possible to select any of the red "dots" to 
see more details of a specific study. The window that opens is the one shown in Figure 18 
where you can read all the information regarding the examination including the age of the  
patient, the number of projections made, the dose to the breast. Interesting is also the 
histogram in red which represents the frequency with which tests were performed for each 
dose range. A yellow arrow show where  the study in question is placed  and then compare 
it with the others. Finally, it is also possible to access the specific examination and in the 
table below i (Figure 18) we can read for each of the four projection made (RCC LMLO,  
RMLO,  LCC)  the  parameters  used:  kV,  mAs,  compressive  strength,  thickness  of  the 
compressed  breast.   
Fig. 18: Details regarding a specific study completed  on   16/04/2014 with  GE2 mammograph .
With TQM it can be seen for each equipment which are the most used settings in terms of  
coupling anode / filter and kV, and  it can be seen for each of them shows the number of 
projections made, the value of minimum dose, maximum, mean and median, standard 
deviation and the average thickness of the compressed breast. It's also possible to have 
an overview of the different pairs anode / filter used in each of the individual projections 
and the dose value related to those as shown in Fig 19. Each symbol on the graphs a, b 
and c refers to a different choice of 'coupling anode / filter; in the abscissa is shown the 
thickness of the compressed breast expressed in mm and in ordinate the value of AGD 
relative to each of the projections of all the examinations considered. On mammography 
Giotto (Fig.19a)  is used exclusively the tungsten anode and the filter  of  rhodium. The 
mammography GE1 and  GE2 have  three  possible  pairs  anode /  filter:  molybdenum / 
molybdenum, molybdenum / rhodium or rhodium / rhodium that are used respectively for  
increasing thickness of the compressed breast. This is because materials with different 
atomic number Z create different radiation spectrum; a greater thickness of the breast in 
fact requires a  harder beam in terms of energy and this can be achieved varying the 
material of which is made the anode and the material with which the beam of photons is 
filtered output to the tube.
    
Fig. 19:  Graphs showing the delivered dose in each projection for all  exams as a function of the breast  
thickness  and  split  according  to  different  anode-filter  coupling.  Graphs   (a),  (b)  and   (c)  refer  to  
mammographs  Giotto, GE1 e GE2 respectively.   
How shown in these three graphs  there is a trend of increasing type of the value of dose  
as a function of the thickness of the compressed breast, slightly more pronounced in the 
mammography Giotto. 
The TQM software also offers the ability to view the compressive force applied expressed 
in Newtons and the thickness of the compressed breast by means of histograms. 
The three graphs below show the plot of the mean AGD value according to the thickness 
of the compressed breast step of 1 mm, from 3.0 cm to 7.4 cm. In blue are the values for 
the data of the three devices while the two curves in gray and green represent European 
values of Dignostic Reference Levels (DRLs) respectively considered acceptable (ACC = 
acceptable) and desirable (ACH = achievable)
Fig.20 (a. Giotto, b.GE, c. GE) Mean AGD value as a function of the thickness of the compressed breast. GE 
mammographs show convenient values  of mean AGD also for higher thickness values, possibly due to  
flexible multiple possibilities of anode-filter coupling modulated on the basis of breast thickness.
4. INTEGRATED DIAGNOSTIC APPROACH IN A BREAST CENTRE 
4.1 The  “joint CORD”
With the aim of optimizing the path within the Centre Senologico of those patients who 
access the path of urgency with nonspecific symptoms and may conclude in all probability 
their diagnostic iter  with a breast ultrasound and a clinical breast examination, was 
established from 16th January to 11th April 2014 a weekly session of  “joint CORD” where 
the session was handled by the cooperation of a junior breast surgeon and senior 
Radiology resident.
This allowed  first  to break down the waiting lists of the traditional radiological CORD 
(active 5 days a week with 8 patients per day for breast emergencies ) that is able to 
concentrate on disposing of waiting lists of patients with symptoms more suspicious, and 
second to concentrate the accesses of patients with chronic non-specific symptoms but 
that would require, however, at least an ultrasound and a clinical breast examination to 
conclude theri diagnostic iter in a single day.
They had access to this service 95 patients, selected by the nursing staff that manages the 
lists of traditional work of CORD.Were performed 12 sessions of CORD JOINT with an 
average of 7.9 patients for session.
If patient had an age of 40aa and did not make a mammogram in the last year, or that 
there was a substantial  clinical or ultrasound suspicion, a  mammogram was performed 
and it was reported  by a breast Radiologist (resident cannot  report an instrumental 
examinations using ionizing radiations). If a  fine-needle aspiration is required, it has been 
executed  immediatly.
Further study using magnetic resonance imaging (MRI) or stereotactic biopsy were instead 
programmed due to organizational issues at our centerin another date.
Of the 95 patients who have had access to this service, 33 had an examination performed 
elsewhere with detection of suspicious nodules or were controls at 6 months of multiple 
fibroadenomatosis , 20 have palpable nodules, 16 have unilateral or bilateral breast pain, 5 
mastitis, 5 for swelling / hyperemia or collection after QUART, 4 secretion (milky) and 12 
others for various reasons (axillary swelling, prediction of hormonal therapies, skin nodule, 
adenoma of the nipple).
Fig 21  Reasons for access to the joint CORD service. 
Of the 95 patients, all of them have benefited  of ultrasound and clinical breast 
examination. In 24 cases (25.2%) mammograms were performed for completion. In 6 
cases (6.3%) was scheduled an MRI. In 2 cases (2, 1%) was requested a withdrawal 
under stereotactic guidance.
Twenty-three Cytological examinations were performed (24.2%), for 2 cases of mammary
 secretions and  21 cases a nodularity of the first response. Such cytology in 15 cases had 
reflected C2 (benign findings) with the conclusion of the process, in 2 cases C3 (probably 
benign finding) and was planned and carried out a histological sampling in both cases 
yielded B2 (benign finding, fibroadenoma), in 4 cases C1 (inadequate sampling) on which 
were planned and carried out 2 biopsies (B2), was a repeated cytology (about 8cm mass 
of mostly liquid), and a lady refused further investigations (the was attached a request for 
histological examination).
The CORD JOINT allowed patients to finish their process through a single access 
concentrating at the time they remain in the breast imaging center.
 4.2  Interdisciplinary meetings
In 2000 Eusoma, the European Society of Breast Cancer Specialists, published a position 
paper “The Requirements of a Specialist Breast Unit”. This document represented the 
starting point towards accomplishing that quality assurance programmes for breast 
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services should become mandatoty.
Eusoma has decided to update and revise its paper taking into account advances in 
diagnosis and treatment and evidence based changes in practice that have occurred in 
recent years with respect to the organization of a Breast Centre. The main concepts 
continues to be the multidisciplinary approach to breast cancer care provided by health 
care professionals that are specialists  in and dedicated to breast diagnosis, treatment and 
long-term care.
An suggested in this paper, were istituited weekly Breast Multidisciplinary case 
menagement meetings, to discuss diagnostic preoperative case as well as any other issue 
related to breast cancer patients which requires multidiscilinary discussion.
Were istutuite weekly meetings starting from January 17.
It was analyzed the period  from January 17th to March 27th.
11 meetings were done with a total of 48 cases discussed and an average of 4.36 cases 
discussed per meeting.
At the meetings there were breast radiologists and breast surgeons, but the prospect is to 
extend participation in these meetings to all breast specialists  (oncologists, pathologists, 
radiation oncologists, nuclear medicine).
The meetings were held on Friday from h13 to h14.30 in the meeting room of the breast 
surgery department,  where there is a monitor (50 inch) connected with a computer and 
the RIS / PACS. The cases to be discussed were weekly prepared on slides to speed up 
the display of the same.
The cases could be selected by surgeons or radiologists  without limit of number.
The cases discussed were tabulated to analyze the most frequent causes of problems, 
possible solutions and improvements traits for clinical practice.
Although it is essential and invaluable source of personal growth, it is not always easy 
cooperation and dialogue between two branches so similar but so different. Even find a 
space of time on a weekly basis that would allow a wider adherence to the specialists it 
was not easy, having to reconcile the radiological service marked by strict booking 
agendas  and  the most unpredictable activities of the surgery room.
As in all  effective communication is required the capacity of  listening to each other, and 
respect for professional specialist, in the awareness of the specialistic role of the other.
Of the 48 cases discussed, 9 (18.7%) had an underlying lack of communication / trust 
between radiologists and surgeons, 6 (12.5%) saw an improperly  use of RM which then 
generated more questions than it has resolved ;in 5 cases (10.4%) was required MRI; in 3 
cases (6.25%) was  required greater accountability in the handling of the patient, in 11 
cases (22.9%) the patient came at the end of the diagnostic iteror to  surgery in the 
absence of conclusive cyto-histological diagnosis, in 8 cases (16.6%) was requested a 
further biopsy, in 2 cases (4.1%) a PET scan was performed and give a nonspecific breast 
uptake, in 1 case it was requested a new mammography (2.08%) and in 2 cases (4.1%) 
was evaluated not useful a request of surgical visit.
Fig.22. Interdisciplinary meetings outcome
From this meeting is therefore emerged as the main problems reside in the direct
communication between the two departments, which too often takes place by  what the 
patient reports, creating unnecessary confusion and on how too often surgeons do not 
cosideri concluded the diagnostic iter if there is a MRI with multiple enhancements and a 
negative second-look ultrasound, this problem widely known for the high sensitivity of MRI. 
It is necessary to adhere strictly to the instructions of the MR expressed in the guidelines 
of the 'American College of Radiology, reviewed in , 2013, even though sometimes we fall 
into the temptation to prescribe MRI examinations in more complex cases, often increasing 
the complexity of the case. RMI certainly does not provide a diagnosis of the nature. MRI if 
performed outside the guidelines, is likely to become a useless review. For this reason the 
'American College of Radiology has produced guidelines for the use of this method.
The American College of Radiology, with more than 30,000 members, is the principal 
organization of radiologists, radiation oncologists, and clinical
medical physicists in the United States. The College is a nonprofit professional society 
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whose primary purposes are to advance the science of radiology,
improve radiologic services to the patient, study the socioeconomic aspects of the practice 
of radiology, and encourage continuing education for radiologists,
radiation oncologists, medical physicists, and persons practicing in allied professional 
fields.
Current indications for breast MRI include, but are not limited to: 
1. Screening
a. For high-risk patients –  MRI can significantly improve the detection of cancer 
that is otherwise clinically, mammographically, and sonographically occult . Patients should 
be referred for screening breast MRI.  Breast MRI may be indicated in the surveillance of 
women with more than a 20% lifetime risk of breast cancer (for example, individuals with 
genetic predisposition to breast cancer by either gene testing or family pedigree, or 
individuals with a history of mantle radiation for Hodgkin’s disease). Although there is no 
direct evidence that screening with MRI will reduce mortality, it is thought that early 
detection by using annual MRI as surveillance, in addition to mammography, may be 
useful.
b. For patients with a new breast malignancy - Screening of the contralateral 
breast with MRI in patients with a new breast malignancy can detect occult malignancy in 
the contralateral breast in at least 3% to 5% of breast cancer patients. 
c. For patients with breast augmentation - Breast MRI using contrast may be 
indicated in the evaluation of patients with silicone or saline implants and/or free injections 
with silicone, paraffin, or polyacrylamide gel in whom mammography is difficult. The 
integrity of silicone implants can be determined by noncontrast MRI.
2. Extent of disease
a. Invasive carcinoma and ductal carcinoma in situ (DCIS) – Breast MRI may be 
useful to determine the extent of disease and the presence of multifocality and 
multicentricity in patients with invasive carcinoma and ductal carcinoma in situ (DCIS). MRI 
determines the extent of disease more accurately than standard mammography and 
physical examination in many patients. It remains to be shown conclusively, however, that 
this increased accuracy results in any reduction in recurrence rates following surgery, 
radiation, or systemic therapy.
b. Invasion deep to fascia – MRI evaluation of breast carcinoma prior to surgical 
treatment may be useful in both mastectomy and breast conservation candidates to define 
the relationship of the tumor to the fascia and its extension into pectoralis major, serratus 
anterior, and/or intercostal muscles .
c. Postlumpectomy with positive margins – Breast MRI may be used in the 
evaluation of residual disease in patients whose pathology specimens demonstrate close 
or positive margins for residual disease.
d. Neoadjuvant chemotherapy – Breast MRI may be useful before, during, and/or 
after chemotherapy to evaluate treatment response and the extent of residual disease 
prior to surgical treatment.
3. Additional evaluation of clinical or imaging findings
a. Recurrence of breast cancer – Breast MRI may be useful in women with a prior 
history of breast cancer and suspicion of recurrence when clinical, mammographic, and/or 
sonographic findings are inconclusive.
b. Metastatic cancer when the primary is unknown and suspected to be of breast 
origin – MRI may be useful in patients presenting with metastatic disease and/or axillary 
adenopathy and no mammographic or physical Clinical trials demonstrate that breast MRI 
can locate primary tumor in the breast in over half of women presenting with metastatic 
axillary adenopathy and an occult primary. Breast MRI can also define the disease extent 
to facilitate treatment planning.
c. Lesion characterization – In rare cases, breast MRI may be indicated when 
other imaging examinations, such as ultrasound and mammography, and physical 
examination are inconclusive for the presence of breast cancer, and biopsy cannot be 
performed (e.g., possible distortion on only one mammographic view without a 
sonographic correlate). MRI should not replace ultrasound or diagnostic mammography to 
evaluate clinical focal signs or symptoms in the breast or to evaluate lesions identified on 
screening mammography.
d. Postoperative tissue reconstruction – Breast MRI may be useful in the 
evaluation of suspected cancer recurrence in patients with tissue transfer flaps.
e. MRI-guided biopsy – MRI is indicated for guidance of interventional procedures 
such as vacuum assisted biopsy and preoperative wire localization for lesions that are 
occult on mammography or sonography and demonstrable only with MRI.
B. Other Considerations
Screening of general population Screening breast MRI is not recommended for the general 
population of asymptomatic, average-risk women. False positives
Breast MRI may yield findings that are not evident clinically or on mammography or 
ultrasound. The findings may or may not be clinically significant. As with mammography or 
any other diagnostic test, false positive results can be expected, and the literature shows a 
wide range of specificity for breast MRI. The additional abnormalities detected on MRI may 
result in a follow-up examination or recommendation for biopsy. Published results for MRI 
directed biopsy are similar to those for mammography.
Treatment choices
Information from the MRI may change the planned treatment management. Caution should 
be exercised in changing management based on MRI findings alone without initial biopsy 
confirmation. Additional biopsies and/or correlation with other clinical and imaging 
information should be used together with clinical judgment. There is currently no evidence 
that identification of additional ipsilateral or contralateral occult malignancies improves 
patient outcomes.
4.Inappropriate uses of breast MRI
MRI should not supplant careful problem-solving mammographic views or ultrasound in 
the diagnostic setting. Because MRI will miss some cancers that mammography will 
detect, it should not be used as a substitute for screening mammograms. MRI should not 
be used in lieu of biopsy of a mammographically, clinically, and/or sonographically 
suspicious finding.
MRI does not always solve the problems.
Here an example of a woman of 37 years with a  history family of breast cancer (mother and 
maternal grandmother) who has ultrasound examination in the retro-areolar (RA) area of epithelial  
hyperplasia with microcysts and internal hyperechoic spots related to precipitation of calcium salts  
within the microcysts (with corresponding Mammographic punctate and granular 
microcalcifications) in the context of cystic dysplasia and diffuse microcystic also dense in content.
Fig 23 US image
Fig 24: Right mammograms.
It is planned to complete diagnostic MRI and histological planned withdrawal of 
microcalcifications. 
The MRI, however, showed multiple, bilateral  nodules  with a RA dx 4 nodularity and 
multiple focus enhancement bilaterally.
Fig 25 MRI 
Follows US-guided biopsy of the region RA dx with a histological diagnosis of "atypical 
ductal hyperplasia, adenosis and small area with pseudopapillary aspects." The patient is 
then sent to the surgical visit  for multinodular retroareolar area on the  right (RM3, U4, 
R4b, B3) in a patient with bilateral complex breast R0-R3, R3 U3 also at h6 SIN. 
It 'also important to establish clear diagnostic pathways to define which patients  in staging 
should undergo preoperative MRI examination. 
Is the  example of the patient 47aa, which as a result of mammography performed (Fig.26) 
with highlights of microcalcifications R5 in the QIE SIN thenbenign at histologic sampling 
performed in stereotactic guidance, however, being recommended excision of the region 
for the suspicious appearance of microcalcifications, however, was deemed unfit for the 
execution of the preoperative MRI in relation to the structure of the mammary fat.
Fig 26  : Mammography showing microcalcifications
 
Fig 27 Mammography magnification showing microcalcifications
Another aspect that emerged is the assumptionof responsibility by radiologists and 
surgeons for the management of the patient, controversial for medico-legal issues. Two 
pratical examples follows.
Case 1: Lady of 45 years with thickening visible on mammography in charge of the left 
breast (R4a, U2, RM2, B2). Several ultrasound and mammographic controls idocumented 
stability of the left glandular plaque. MRI test required after 6 months
Fig 28 MRI breast scan (left, T2w; right T1w+contrast)
MRI performed after 6 months show dimensional,  morphological plaque stability and the 
same type of enhancement. However  It  planned a stereotaxis biopsy with result of 
"replaced with fibrous mammary fat" (B1). 
Although finding show stabilitylsince 2012,  the radiologist suggest the possibility of a MRI 
guided biopsy or excision. 
Case 2: Woman 36yrs. Familiarity for breast cancer. US findings show a nodule on the left 
QSE classified probably malignant (U4)  which underwent two biopsies with outcome B1 in 
2011. Cytology of axillary lymph nodes negative for malignant cells.
In May 2012, the patient's routine ultrasound finding which confirms the stability of the U4, 
9.5 mm SIN QSE.
Fig 29 Ultrasound breast scan, U4 nodule.
Performs MRI in June 2012, which was negative. 
Ultrasound scans November 2012 and July 2013, unchanged. 
Visit breast surgery in November 2013, which assesses the tests performed, and 
concludes that although the findings are stable, having been the nodule at first classified 
as probably malignant, there is ample indication for resection.
5. CONCLUSIONS 
Radiology is an essential step in the clinical management of the breast patient. The quality 
of the diagnostic service is crucial in ensuring timeliness and accuracy in clinical decisions, 
quickly bringing the planning surgical patients candidates for surgery.
The control of the dose and the diagnostic work-up optimization (e.g. number of accesses) 
is part of the quality checks to be carried out.
For a good functioning of the Breast Center, is necessary that radiologists derive maximum 
information content from the tests performed in order to conclude the process, and that 
there is a relationship of mutual trust with the surgeons.
Next steps in this direction will be the application for accreditation of multidisciplinary 
meetings and the drafting of a report on the same testimony and shared decision-making, 
in line with the requirements of the new  Eusoma directive.
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